Healthy way of life, metabolomic signature, and threat of late-onset schizophrenia: proof from the potential cohort

Lehman, A. F. et al. Practice guideline for the remedy of sufferers with schizophrenia, second version. Am. J. Psychiatry. 161, 1–56 (2004).

Google Scholar 

Laursen, T. M., Nordentoft, M. & Mortensen, P. B. Excess early mortality in schizophrenia. Annu. Rev. Clin. Psychol. 10, 425–448 (2014).

Google Scholar 

Howard, R., Rabins, P. V., Seeman, M. V. & Jeste, D. V. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: a world consensus. Int. Late-Onset Schizophrenia Group. Am. J. Psychiatry 157, 172–178 (2000).

Google Scholar 

van Os, J., Kenis, G. & Rutten, B. P. The setting and schizophrenia. Nature 468, 203–212 (2010).

Google Scholar 

Stilo, S. A. & Murray, R. M. Non-genetic components in schizophrenia. Curr. Psychiatry Rep. 21, 100 (2019).

Google Scholar 

Cougnard, A. et al. Does regular developmental expression of psychosis mix with environmental threat to trigger persistence of psychosis? A psychosis proneness-persistence mannequin. Psychol. Med. 37, 513–527 (2007).

Google Scholar 

Stepniak, B. et al. Accumulated environmental threat figuring out age at schizophrenia onset: a deep phenotyping-based research. Lancet Psychiatry. 1, 444–453 (2014).

Google Scholar 

Padmanabhan, J. L., Shah, J. L., Tandon, N. & Keshavan, M. S. The “polyenviromic risk score”: Aggregating environmental threat components predicts conversion to psychosis in familial high-risk topics. Schizophr. Res. 181, 17–22 (2017).

Google Scholar 

Firth, J. et al. A meta-review of “lifestyle psychiatry”: the position of train, smoking, food plan and sleep within the prevention and remedy of psychological problems. World Psychiatry 19, 360–380 (2020).

Google Scholar 

Gurillo, P., Jauhar, S., Murray, R. M. & MacCabe, J. H. Does tobacco use trigger psychosis? Systematic overview and meta-analysis. Lancet Psychiatry 2, 718–725 (2015).

Google Scholar 

Wootton, R. E. et al. Evidence for causal results of lifetime smoking on threat for melancholy and schizophrenia: a Mendelian randomisation research. Psychol. Med. 50, 2435–2443 (2020).

Google Scholar 

Gage, S. H. et al. Investigating causality in associations between smoking initiation and schizophrenia utilizing Mendelian randomization. Sci. Rep. 7, 40653 (2017).

Google Scholar 

Brokmeier, L. L. et al. Does bodily exercise scale back the chance of psychosis? A scientific overview and meta-analysis of potential research. Psychiatry Res. 284, 112675 (2020).

Google Scholar 

Kirli, U., Binbay, T., Alptekin, Ok., Kayahan, B. & Elbi, H. The relationship between alcohol-cannabis use and irritating occasions with the event of incident medical psychosis in a community-based potential cohort. Turk. Psikiyatr. Derg. 32, 235–245 (2021).

Google Scholar 

Andreu-Bernabeu, Á et al. Polygenic contribution to the connection of loneliness and social isolation with schizophrenia. Nat. Commun. 13, 51 (2022).

Google Scholar 

Hoang, T. D. et al. Effect of early grownup patterns of bodily exercise and tv viewing on midlife cognitive operate. JAMA Psychiatry 73, 73–79 (2016).

Google Scholar 

Raichlen, D. A. et al. Sedentary conduct and incident dementia amongst older adults. Jama 330, 934–940 (2023).

Google Scholar 

Tian, F. et al. Plasma metabolomic signature of wholesome way of life, structural mind reserve and threat of dementia. Brain. 148, 143–153 (2025).

Google Scholar 

Szoke, A. et al. Multimorbidity and the etiology of schizophrenia. Curr. Psychiatry Rep. 26, 253–263 (2024).

Google Scholar 

Jahrami, H. A., Faris, M. A. E., Saif, Z. Q. & Hammad, L. H. Assessing dietary and way of life threat components and their associations with illness comorbidities amongst sufferers with schizophrenia: a case-control research from Bahrain. Asian J. Psychiatr. 28, 115–123 (2017).

Google Scholar 

Tolstikov, V., Moser, A. J., Sarangarajan, R., Narain, N. R. & Kiebish, M. A. Current standing of metabolomic biomarker discovery: influence of research design and demographic traits. Metabolites. 10, (2020).

Delgado-Velandia, M. et al. Healthy way of life, metabolomics and incident kind 2 diabetes in a population-based cohort from Spain. Int J. Behav. Nutr. Phys. Act. 19, 8 (2022).

Google Scholar 

Wang, Y. et al. Healthy way of life, metabolic signature, and threat of cardiovascular ailments: a population-based research. Nutrients. 16, (2024).

Fernandez, C. et al. Plasma lipidome and prediction of kind 2 diabetes within the population-based Malmö food plan and most cancers cohort. Diab. Care 43, 366–373 (2020).

Google Scholar 

Sudlow, C. et al. UK Biobank: an open entry useful resource for figuring out the causes of a variety of advanced ailments of center and previous age. PLoS Med. 12, e1001779 (2015).

Google Scholar 

Han, H. et al. Association of a wholesome way of life with all-cause and cause-specific mortality amongst people with kind 2 diabetes: a potential research in UK Biobank. Diab. Care 45, 319–329 (2022).

Google Scholar 

Wang, B. et al. Association of mixed wholesome way of life components with incident dementia in sufferers with kind 2 diabetes. Neurology. 99, e2336–e2345 (2022).

Google Scholar 

Tian, F. et al. Post-cardiovascular illness wholesome way of life, irritation and metabolic biomarkers, and threat of dementia: a population-based longitudinal research. Am. J. Clin. Nutr. 121, 511–521 (2025).

Google Scholar 

Zhang, Y. B. et al. Associations of wholesome way of life and socioeconomic standing with mortality and incident heart problems: two potential cohort research. Bmj 373, n604 (2021).

Google Scholar 

Navratilova, H. F., Lanham-New, S., Whetton, A. D. & Geifman, N. Associations of food plan with well being outcomes within the UK Biobank: a scientific overview. Nutrients 16, (2024).

Smith, R. W. et al. Social isolation and threat of coronary heart illness and stroke: evaluation of two massive UK potential research. Lancet Public Health 6, e232–e239 (2021).

Google Scholar 

Julkunen, H., Cichońska, A., Slagboom, P. E. & Würtz, P. Metabolic biomarker profiling for identification of susceptibility to extreme pneumonia and COVID-19 within the normal inhabitants. Elife 10, (2021).

Zhuang, Z. et al. Sleep patterns, plasma metabolome, and threat of incident kind 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 108, e1034–e1043 (2023).

Google Scholar 

Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear fashions through coordinate descent. J. Stat. Softw. 33, 1–22 (2010).

Google Scholar 

Shi, B., Choirat, C., Coull, B. A., VanderWeele, T. J. & Valeri, L. CMAverse: a set of capabilities for reproducible causal mediation analyses. Epidemiology 32, e20–e22 (2021).

Google Scholar 

Pedersen, E. M. et al. ADuLT: An environment friendly and strong time-to-event GWAS. Nat. Commun. 14, 5553 (2023).

Google Scholar 

Didelez, V. & Sheehan, N. Mendelian randomization as an instrumental variable method to causal inference. Stat. Methods Med. Res. 16, 309–330 (2007).

Google Scholar 

Wei, Y. et al. Metabolic profiling of smoking, associations with kind 2 diabetes and interplay with genetic susceptibility. Eur. J. Epidemiol. 39, 667–678 (2024).

Google Scholar 

Würtz, P. et al. Metabolic profiling of alcohol consumption in 9778 younger adults. Int. J. Epidemiol. 45, 1493–1506 (2016).

Google Scholar 

Muth, N. D., Laughlin, G. A., von Mühlen, D., Smith, S. C. & Barrett-Connor, E. High-density lipoprotein subclasses are a possible middleman between alcohol consumption and lowered threat of heart problems: the Rancho Bernardo Study. Br. J. Nutr. 104, 1034–1042 (2010).

Google Scholar 

Wang, F. et al. Plasma metabolite profiles associated to plant-based diets and the chance of kind 2 diabetes. Diabetologia 65, 1119–1132 (2022).

Google Scholar 

Li, J. et al. The Mediterranean food plan, plasma metabolome, and heart problems threat. Eur. Heart J. 41, 2645–2656 (2020).

Google Scholar 

Esko, T. et al. Metabolomic profiles as dependable biomarkers of dietary composition. Am. J. Clin. Nutr. 105, 547–554 (2017).

Google Scholar 

Akbaraly, T. et al. Association of circulating metabolites with nutritious diet and threat of heart problems: evaluation of two cohort research. Sci. Rep. 8, 8620 (2018).

Google Scholar 

Pang, Y. et al. Physical exercise, sedentary leisure time, circulating metabolic markers, and threat of main vascular ailments. Circ. Genom. Precis Med. 12, 386–396 (2019).

Google Scholar 

Xiang, H. et al. Association of social isolation and plasma metabolites with the chance of venous thromboembolism. Arterioscler. Thromb. Vasc. Biol. 45, 332–340 (2025).

Google Scholar 

Das, U. N. Polyunsaturated fatty acids and their metabolites within the pathobiology of schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 42, 122–134 (2013).

Google Scholar 

Kurowska, A., Ziemichód, W., Herbet, M. & Piątkowska-Chmiel, I. The position of food plan as a modulator of the inflammatory course of within the neurological ailments. Nutrients 15, (2023).

Goh, Ok. Ok., Chen, C. Y., Chen, C. H. & Lu, M. L. Effects of omega-3 polyunsaturated fatty acids dietary supplements on psychopathology and metabolic parameters in schizophrenia: a meta-analysis of randomized managed trials. J. Psychopharmacol. 35, 221–235 (2021).

Google Scholar 

Rarinca, V. et al. Relevance of food plan in schizophrenia: a overview specializing in prenatal dietary deficiency, weight problems, oxidative stress and irritation. Front. Nutr. 11, 1497569 (2024).

Google Scholar 

Tkachev, A. et al. Lipid alteration signature within the blood plasma of people with schizophrenia, melancholy, and bipolar dysfunction. JAMA Psychiatry 80, 250–259 (2023).

Google Scholar 

Tajik-Esmaeeli, S. et al. Simvastatin adjunct remedy for damaging signs of schizophrenia: a randomized double-blind placebo-controlled trial. Int. Clin. Psychopharmacol. 32, 87–94 (2017).

Google Scholar 

Vincenzi, B. et al. A randomized placebo-controlled pilot research of pravastatin as an adjunctive remedy in schizophrenia sufferers: impact on irritation, psychopathology, cognition and lipid metabolism. Schizophr. Res. 159, 395–403 (2014).

Google Scholar 

Shen, H. et al. Adjunctive remedy with statins in schizophrenia sufferers: a meta-analysis and implications. Psychiatry Res. 262, 84–93 (2018).

Google Scholar 

Murphy, C. E., Walker, A. Ok. & Weickert, C. S. Neuroinflammation in schizophrenia: the position of nuclear issue kappa B. Transl. Psychiatry 11, 528 (2021).

Google Scholar 

Belalcazar, L. M. et al. A 1-year way of life intervention for weight reduction in people with kind 2 diabetes reduces excessive C-reactive protein ranges and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) research. Diab. Care 33, 2297–2303 (2010).

Google Scholar 

Valenzuela, P. L. et al. Lifestyle interventions for the prevention and remedy of hypertension. Nat. Rev. Cardiol. 18, 251–275 (2021).

Google Scholar 

Ornish, D. et al. Intensive way of life adjustments for reversal of coronary coronary heart illness. Jama 280, 2001–2007 (1998).

Google Scholar 

Zhao, X., Zhang, S., Sanders, A. R. & Duan, J. Brain lipids and lipid droplet dysregulation in Alzheimer’s illness and neuropsychiatric problems. Complex Psychiatry 9, 154–171 (2023).

Google Scholar 

Yeo, I. J. et al. Overexpression of transmembrane TNFα in mind endothelial cells induces schizophrenia-relevant behaviors. Mol. Psychiatry 28, 843–855 (2023).

Google Scholar 

González-Castro, T. B. et al. Effects of IL-6/IL-6R axis alterations in serum, plasma and cerebrospinal fluid with the schizophrenia: an up to date overview and meta-analysis of 58 research. Mol. Cell Biochem. 479, 525–537 (2024).

Google Scholar 

Huang, J. Ok. & Lee, H. C. Emerging proof of pathological roles of very-low-density lipoprotein (VLDL). Int. J. Mol. Sci. 23, (2022).

Bazinet, R. P. & Layé, S. Polyunsaturated fatty acids and their metabolites in mind operate and illness. Nat. Rev. Neurosci. 15, 771–785 (2014).

Google Scholar 

Janssen, C. I. & Kiliaan, A. J. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the affect of LCPUFA on neural growth, getting old, and neurodegeneration. Prog. Lipid Res 53, 1–17 (2014).

Google Scholar 

Devassy, J. G., Leng, S., Gabbs, M., Monirujjaman, M. & Aukema, H. M. Omega-3 polyunsaturated fatty acids and oxylipins in neuroinflammation and administration of Alzheimer illness. Adv. Nutr. 7, 905–916 (2016).

Google Scholar 

Navarro, C. et al. Influence of polyunsaturated fatty acids on Cortisol transport by MDCK and MDCK-MDR1 cells as blood-brain barrier in vitro mannequin. Eur. J. Pharm. Sci. 42, 290–299 (2011).

Google Scholar 

Wen, J. et al. Unraveling the influence of Omega-3 polyunsaturated fatty acids on blood-brain barrier (BBB) integrity and glymphatic operate. Brain Behav. Immun. 115, 335–355 (2024).

Google Scholar 

Banks, W. A. The blood-brain barrier in neuroimmunology: tales of separation and assimilation. Brain Behav. Immun. 44, 1–8 (2015).

Google Scholar 

Zhang, W. J., Sweeney, J. A., Bishop, J. R., Gong, Q. Y. & Lui, S. Biological subtyping of psychiatric syndromes as a pathway for advances in drug discovery and customized drugs. NATURE MENTAL HEALTH 1, 88–99 (2023).

Google Scholar 

Du, W., Tang, B. Q., Liu, S. H., Zhang, W. J. & Lui, S. Causal associations between iron ranges in subcortical mind areas and psychiatric problems: a Mendelian randomization research. Transl. Psychiatry 15, (2025).

Zhang, W., Qiu, C. & Lui, S. Imaging biomarker research of antipsychotic-naïve first-episode schizophrenia in China: progress and future instructions. Schizophr. Bull. 51, 379–391 (2025).

Google Scholar 

Paul, T. et al. Neurostructural adjustments in schizophrenia and treatment-resistance: a story overview. Psychoradiology 4, kkae015 (2024).

Google Scholar 

Li, R. et al. Effects of olanzapine remedy on lipid profiles in sufferers with schizophrenia: a scientific overview and meta-analysis. Sci. Rep. 10, 17028 (2020).

Google Scholar 

Dai, S. et al. A complete metabolomic and lipidomic research of olanzapine within the remedy of first-episode schizophrenia. Asian J. Psychiatr. 105, 104387 (2025).

Google Scholar 

Aquino, A. et al. Blood-based lipidomics method to guage biomarkers related to response to olanzapine, risperidone, and quetiapine remedy in schizophrenia sufferers. Front. Psychiatry 9, 209 (2018).

Google Scholar 

Meyer, J. M. & Correll, C. U. Increased metabolic potential, efficacy, and security of rising remedies in schizophrenia. CNS Drugs 37, 545–570 (2023).

Google Scholar 

Darke, P. et al. Curating a longitudinal analysis useful resource utilizing linked main care EHR data-a UK Biobank case research. J. Am. Med. Inf. Assoc. 29, 546–552 (2022).

Google Scholar